Divi’s Labs signs long-term supply deal with global pharma company

To support the new partnership and future growth, Divi’s Laboratories plans to invest between ₹650 crore and ₹700 crore in capacity expansion at its existing manufacturing facilities.

Leave a Reply

Your email address will not be published. Required fields are marked *